Help Patients With Skyrocketing Insulin Costs

August 2019

One in four patients with diabetes will ration or even stop their insulin due to skyrocketing costs...sometimes leading to death.

In the U.S., only 3 companies make insulin...driving up prices.

You'll see more efforts to address costs...such as co-pay caps from some payers and states. And FDA is exploring ways to promote competition.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote